ื”ืขื“ืคืชื›ื ืขื•ื“ื›ื ื” ืขื‘ื•ืจ ื”ืžืคื’ืฉ ื”ื–ื”. ื›ื“ื™ ืœืฉื ื•ืช ืืช ื”ื’ื“ืจืช ื”ื—ืฉื‘ื•ืŸ ืœืฆืžื™ืชื•ืช, ืขื‘ืจื• ืืœ
ืœื”ื–ื›ื™ืจื›ื, ื ื™ืชืŸ ืœืขื“ื›ืŸ ืืช ื”ืžื“ื™ื ื” ืื• ื”ืฉืคื” ื”ืžื•ืขื“ืคื•ืช ืขืœื™ื›ื ื‘ื›ืœ ืขืช ื‘
> beauty2 heart-circle sports-fitness food-nutrition herbs-supplements pageview
לחצו להצגת הצהרת הנגישות שלנו

תוספי L-טירוזין: יתרונות, תועולת בסטרס ועוד

86,711 צפיות

anchor-icon תוכן העניינים dropdown-icon
anchor-icon תוכן העניינים dropdown-icon

ืžื”ื• L-ื˜ื™ืจื•ื–ื™ืŸ?

L-ื˜ื™ืจื•ื–ื™ืŸ ื”ื™ื ื—ื•ืžืฆืช ืืžื™ื ื• ืฉืื™ื ื” ื—ื™ื•ื ื™ืช ื•ืชื—ื™ืœืŸ ืฉืœ ื”ื•ืจืžื•ื ื™ ื‘ืœื•ื˜ืช ื”ืชืจื™ืก, ื”ืžื•ืœื™ื›ื™ื ื”ืขืฆื‘ื™ื™ื ื“ื•ืคืžื™ืŸ ื•ื ื•ืจืืคื™ื ืคืจื™ืŸ ื•ื”ื•ืจืžื•ืŸ ื”ืกื˜ืจืก ืืคื™ื ืคืจื™ืŸ. L-ื˜ื™ืจื•ื–ื™ืŸ ื”ื™ื ื—ื•ืžืฆืช ืืžื™ื ื• ืฉืื™ื ื” ื—ื™ื•ื ื™ืช, ื›ืš ืฉื”ื’ื•ืฃ ื™ื›ื•ืœ ืœื™ื™ืฆืจ L-ื˜ื™ืจื•ื–ื™ืŸ ืžื—ื•ืžืฆืช ืืžื™ื ื• ืื—ืจืช, Lโ€Žืคื ื™ืœืืœื ื™ืŸ, ื•ื‘ื“ืจืš ื›ืœืœ ืื™ืŸ ืฆื•ืจืš ืœืงื‘ืœ L-ื˜ื™ืจื•ื–ื™ืŸ ื™ืฉื™ืจื•ืช ืžื”ืชื–ื•ื ื”. ืขื ื–ืืช, ื™ืฉ ืื ืฉื™ื ืขื ื”ืคืจืขื” ื’ื ื˜ื™ืช ื ื“ื™ืจื” ื”ืžื›ื•ื ื” "ืคื ื™ืœืงื˜ื•ื ื•ืจื™ื”" (PKU) ืฉืื™ื ื ื™ื›ื•ืœื™ื ืœื™ื™ืฆืจ ืืช ื—ื•ืžืฆืช ื”ืืžื™ื ื• L-ืคื ื™ืœืืœื ื™ืŸ. ืขื‘ื•ืจ ื”ืื ืฉื™ื ื”ืืœื”, L-ื˜ื™ืจื•ื–ื™ืŸ ื”ื™ื ื—ื•ืžืฆืช ืืžื™ื ื• ื—ื™ื•ื ื™ืช. ืžื˜ื•ืคืœื™ื ืขื PKU ื—ื™ื™ื‘ื™ื ืœื”ื—ืœื™ืฃ ืืช L-ืคื ื™ืœืืœื ื™ืŸ ื‘-L-ื˜ื™ืจื•ื–ื™ืŸ, ืื—ืจืช ื”ื ื™ืคืชื—ื• ื ื–ืง ืžื•ื—ื™. ื‘ื“ืจืš ื›ืœืœ ืขื•ืฉื™ื ืืช ื”ื‘ื“ื™ืงื” ื”ื ื“ืจืฉืช ื•ืžืื‘ื—ื ื™ื ืืช ื”ืžื—ืœื” ืืฆืœ ืžื™ ืฉืกื•ื‘ืœื™ื ืžืžื ื” ืื—ืจื™ ื”ืœื™ื“ื”.

L-ื˜ื™ืจื•ื–ื™ืŸ ื”ื•ื ืชื—ื™ืœืŸ ืฉืœ ืžื•ืœื™ื›ื™ื ืขืฆื‘ื™ื™ื, ื•ืœื›ืŸ ืžื—ืงืจื™ื ื‘ื—ื ื• ืืช ื”ืชื•ืขืœืช ืฉืœื• ืœื‘ืจื™ืื•ืช ื”ื ืคืฉ. ืืžื ื ื—ืœืง ืžื”ืฉื™ืžื•ืฉื™ื ืžื—ื™ื™ื‘ื™ื ืžื—ืงืจ ื ื•ืกืฃ, ืื‘ืœ ื™ืฉ ื›ืžื” ืžืžืฆืื™ื ืžืขื ื™ื™ื ื™ื.

ืชื•ืขืœืช ื‘ื“ื™ื›ืื•ืŸ

ื›ืžื” ืžื”ืชืจื•ืคื•ืช ื”ืกื˜ื ื“ืจื˜ื™ื•ืช ืœื˜ื™ืคื•ืœ ื‘ื“ื™ื›ืื•ืŸ ืžื›ื•ื•ื ื•ืช ืœื“ื•ืคืžื™ืŸ ื•ื ื•ืจืืคื™ื ืคืจื™ืŸ. ื‘ื”ืชืื ืœื–ืืช, L-ื˜ื™ืจื•ื–ื™ืŸ ืขืฉื•ื™ ืœื”ื•ื•ืช ื“ืจืš ืคืฉื•ื˜ื” ืœื ืกื•ืช ื•ืœื”ืขืœื•ืช ืืช ืจืžื•ืช ื”ืžื•ืœื™ื›ื™ื ื”ืขืฆื‘ื™ื™ื ื”ืœืœื• ื›ื“ื™ ืœื”ื’ื™ืข ืœืชื•ืฆืื•ืช ื“ื•ืžื•ืช. ืžืขื ื™ื™ืŸ ื›ื™ ืžื—ืงืจื™ื ื‘ื‘ืขืœื™ ื—ื™ื™ื ืžืฆื‘ื™ืขื™ื ืฉื™ืฉ ืœืชื•ืกืคื™ L-ื˜ื™ืจื•ื–ื™ืŸ ืคื•ื˜ื ืฆื™ืืœ ืžืกื•ื™ื ืฉืœ ื”ืฉืคืขื” ื ื•ื’ื“ืช ื“ื™ื›ืื•ืŸ.

ื‘ืžื—ืงืจื™ื ืขืœ ื“ืœื“ื•ืœ ืžืื’ืจื™ L-ื˜ื™ืจื•ื–ื™ืŸ ืžื•ืจื™ื“ื™ื ืืช ืจืžืช L-ื˜ื™ืจื•ื–ื™ืŸ ื‘ืžื•ื— ืขืœ-ื™ื“ื™ ืžืชืŸ ื›ืœ ื—ื•ืžืฆื•ืช ื”ืืžื™ื ื• ืคืจื˜ ืœ-L-ื˜ื™ืจื•ื–ื™ืŸ ื•ื”ืชื—ื™ืœืŸ ืฉืœื• L-ืคื ื™ืœืืœื ื™ืŸ. ืžื—ืงืจื™ื ื‘ื‘ื ื™ ืื“ื ืžืฆืื• ืขืœื™ื™ื” ื‘ืื“ื™ืฉื•ืช ื•ื‘ื—ื•ืกืจ ืกื™ืคื•ืง ืœืื—ืจ ืกื™ืœื•ืง L-ืคื ื™ืœืืœื ื™ืŸ ื•-L-ื˜ื™ืจื•ื–ื™ืŸ. ื›ืžื• ื›ืŸ, ื”ื ื‘ื“ืงื™ื ื’ื ื”ื“ื’ื™ืžื• ื ื˜ื™ื™ื” ืœืคืชื— ืขืฆื‘ื•ืช ื‘ื–ืžืŸ ืฉื”ื ื”ื™ื• ืชื—ืช ืžืขืงื‘. ื”ืชื•ืฆืื•ืช ื”ืœืœื• ืžืฆื‘ื™ืขื•ืช ืขืœ ื›ืš ืฉืžื—ืกื•ืจ ื‘-L-ื˜ื™ืจื•ื–ื™ืŸ ืขืฉื•ื™ ืœื”ืฉืคื™ืข ืขืœ ืžืฆื‘ ื”ืจื•ื—.

ื“ื™ื•ื•ื—ื™ ืžืงืจื” ื™ืฉื ื™ื ืžืชืืจื™ื ืžื˜ื•ืคืœื™ื ืฉืœื ื”ื’ื™ื‘ื• ืœืชืจื•ืคื•ืช ืกื˜ื ื“ืจื˜ื™ื•ืช ืจื‘ื•ืช ื ื’ื“ ื“ื™ื›ืื•ืŸ, ืืš ื”ืฉืชืคืจื• ืชื—ืช L-ื˜ื™ืจื•ื–ื™ืŸ ื›ื˜ื™ืคื•ืœ ืœื“ื™ื›ืื•ืŸ. ื‘ื—ืœืง ืžื“ื™ื•ื•ื—ื™ ื”ืžืงืจื” ื”ื™ื• ืขื“ื•ื™ื•ืช ืœืžื—ืกื•ืจ ื‘ืžื•ืœื™ืš ื”ืขืฆื‘ื™ ื ื•ืจืืคื™ื ืคืจื™ืŸ. ื“ื™ื•ื•ื—ื™ ืžืงืจื” ืื—ืจื™ื ืฉื”ื’ื™ืขื• ืžืฆืจืคืช ืžื“ื•ื•ื—ื™ื ืขืœ ืจื™ืคื•ื™ ืืจื•ืš-ื˜ื•ื•ื— ืฉืœ ื“ื™ื›ืื•ืŸ ื‘ืžื˜ื•ืคืœื™ื ืืฆืœื ื ืžืฆื ืžื—ืกื•ืจ ื‘ื“ื•ืคืžื™ืŸ. ืขื ื–ืืช, ื”ื ื™ืกื•ื™ ื”ืงืœื™ื ื™ ื›ืคื•ืœ-ื”ืกืžื™ื•ืช ื”ื™ื—ื™ื“ ืฉื ืขืจืš ื‘ื ื•ืฉื ื”ื–ื” ืœื ืžืฆื ื›ื™ L-ื˜ื™ืจื•ื–ื™ืŸ ืžื•ืขื™ืœ ื‘ื“ื™ื›ืื•ืŸ, ืืš ื™ืฉ ืœืฆื™ื™ืŸ ื›ื™ ื‘ืžื—ืงืจ ื–ื” ืœื ื ื‘ื“ืงื• ืจืžื•ืช ื“ื•ืคืžื™ืŸ ืื• ื ื•ืจืืคื™ื ืคืจื™ืŸ. ื‘ืžื—ืงืจื™ื ื”ืงื™ื™ืžื™ื ืงื™ื™ืžืช ืชืžื™ื›ื” ื—ื–ืงื” ื™ื•ืชืจ ื‘ืคืจืขื–ืขืคืจืŸ ื•ืื•ืœื™ ื’ื 5-HTP โ€Žื›ื˜ื™ืคื•ืœื™ื ื˜ื‘ืขื™ื™ื ืœื“ื™ื›ืื•ืŸ. ืขื ื–ืืช, ื ื“ืจืฉื™ื ืžื—ืงืจื™ื ื ื•ืกืคื™ื ืฉื™ืขื–ืจื• ืœื”ื‘ื™ืŸ ื˜ื•ื‘ ื™ื•ืชืจ ื”ืื ื™ืฉ ืœ-L-ื˜ื™ืจื•ื–ื™ืŸ ืžืงื•ื ื‘ื˜ื™ืคื•ืœ ื‘ื“ื™ื›ืื•ืŸ, ืื• ืฉืžื ื”ื•ื ืขื•ื–ืจ ืจืง ื‘ืžืงืจื™ื ื‘ื•ื“ื“ื™ื ืขื ืžื—ืกื•ืจ ื‘ืžื•ืœื™ื›ื™ื ืขืฆื‘ื™ื™ื ืกืคืฆื™ืคื™ื™ื.

ืชื•ืขืœืช ื‘ื”ืคืจืขื•ืช ืงืฉื‘, ืจื™ื›ื•ื– ื•ื”ื™ืคืจืืงื˜ื™ื‘ื™ื•ืช (ADHD)

ืจื‘ื™ื ืžืืžื™ื ื™ื ื›ื™ ADHD ื”ื™ื ืžื—ืœื” ืฉืงืฉื•ืจื” ืœืจืžื•ืช ื“ื•ืคืžื™ืŸ ื ืžื•ื›ื•ืช ื‘ืžื•ื—. ื ืจืื” ื›ื™ ืžื ื’ื ื•ืŸ ื”ืคืขื•ืœื” ืฉืœ ืชืจื•ืคื•ืช ืžืžืจื™ืฆื•ืช, ื›ืžื• ืจื™ื˜ืœื™ืŸ ื•ืื“ืจืœ, ืงืฉื•ืจ ืœืคื—ื•ืช ื‘ืื•ืคืŸ ื—ืœืงื™ ืœื”ืขืœืืช ืจืžื•ืŸ ื”ื“ื•ืคืžื™ืŸ ื•ื”ื ื•ืจืืคื™ื ืคืจื™ืŸ. ื‘ื”ืชืื ืœื–ืืช, ืื™ืŸ ื–ื” ืžืคืชื™ืข ืฉืœืคืขืžื™ื ืžืžืœื™ืฆื™ื ืขืœ L-ื˜ื™ืจื•ื–ื™ืŸ ื›ื˜ื™ืคื•ืœ ื‘-ADHD. ืขื ื–ืืช, ื™ืฉ ื ื™ื•ืื ืกื™ื ืฉื•ื ื™ื ื‘ืžื—ืงืจื™ื, ื•ืžืกืคืจ ื”ืžื—ืงืจื™ื ื‘ื ื•ืฉื ื–ื” ื“ื™ ืžื•ื’ื‘ืœ.

ืžื—ืงืจ ืงื˜ืŸ ื‘ื• ื ืชื ื• ืชื•ืกืคื™ L-ื˜ื™ืจื•ื–ื™ืŸ, L-ื˜ืจื™ืคื˜ื•ืคืŸ, ืืžืคื˜ืžื™ืŸ ืื• ืคืœืฆื‘ื• ื‘ืžืฉืš ืฉื‘ื•ืข ืื—ื“ ื‘ืœื‘ื“ ืžืฆื ืฉืื™ืŸ ืชื•ืขืœืช ื‘ืžืชืŸ L-ื˜ื™ืจื•ื–ื™ืŸ ืœื™ืœื“ื™ื ืžื‘ื—ื™ื ืช ืชืกืžื™ื ื™ ADHD. ืžืขื ื™ื™ืŸ ื›ื™, Lโ€Ž-ื˜ืจื™ืคื˜ื•ืคืŸ, ืฉื™ืคื•ืจ ืืช ื”ืชื ื”ื’ื•ืช ื”ื™ืœื“ื™ื ืœืคื™ ื“ื™ื•ื•ื— ื”ื”ื•ืจื™ื. ืžืื—ืจ ืฉื”ืžื—ืงืจ ื”ื™ื” ืžืฆื•ืžืฆื ื•ืงืฆืจ, ืงืฉื” ืœื”ืกื™ืง ืžืžื ื• ืžืกืงื ื•ืช ื›ืœืฉื”ืŸ. ื‘ืžื—ืงืจ ืงื˜ืŸ ืื—ืจ ื‘ืงืจื‘ ืžื‘ื•ื’ืจื™ื ื ืชื ื• L-ื˜ื™ืจื•ื–ื™ืŸ ื‘ืžืฉืš ืฉืžื•ื ื” ืฉื‘ื•ืขื•ืช. ืœืื—ืจ ืฉื‘ื•ืขื™ื™ื, ืชืกืžื™ื ื™ ื”-ADHD ื”ืฉืชืคืจื• ืืฆืœ 75% ืžื”ืžื˜ื•ืคืœื™ื. ืขื ื–ืืช, ื”ืชื•ืขืœืช ื“ืขื›ื” ืœืื—ืจ ืฉื™ืฉื” ืฉื‘ื•ืขื•ืช, ื•ื ืจืื” ืฉืืฆืœ ืืฃ ืื—ื“ ืžื”ืžื˜ื•ืคืœื™ื ื”ืชื•ืขืœืช ืœื ื ืฉืžืจื” ื‘ื˜ื•ื•ื— ื”ืืจื•ืš. ืขื•ืจื›ื™ ื”ืžื—ืงืจ ื”ื’ื™ืขื• ืœืžืกืงื ื” ื›ื™ ื”ืชืคืชื—ื” ืขืžื™ื“ื•ืช ืœ-L-ื˜ื™ืจื•ื–ื™ืŸ, ื›ืš ืฉื—ื•ืžืฆืช ืืžื™ื ื• ื–ื• ืื™ื ื” ื™ืขื™ืœื” ืœื˜ื™ืคื•ืœ ืžืชืžืฉืš ื‘ืชืกืžื™ื ื™ ADHD.

ืคื•ืจืกื ื’ื ื—ืงืจ ืžืงืจื” ืื—ื“ ืขืœ ADHD. ืžื“ื•ื‘ืจ ื‘ื™ืœื“ ืขื PKU, ื”ืžื—ืœื” ื”ื’ื ื˜ื™ืช ื‘ื” ื ื—ืกื ื™ื™ืฆื•ืจ ืฉืœ L-ื˜ื™ืจื•ื–ื™ืŸ ืž-L-ืคื ื™ืœืืœื ื™ืŸ. ื‘ื’ื™ืœ ืฉืœื•ืฉ ื”ื™ืœื“ ื”ืชื—ื™ืœ ืœื”ืคื’ื™ืŸ ื“ืคื•ืกื™ ื”ืชื ื”ื’ื•ืช ืžืืชื’ืจื™ื. ื”ื•ืจื™ื• ืฉืœ ื”ื™ืœื“ ืคื ื• ืœืขื–ืจื” ื‘ื’ืœืœ ื”ืชืกืžื™ื ื™ื ืฉื”ื•ื ืคื™ืชื—. ื‘ืขืงื‘ื•ืช ื”ืขืจื›ืช ืจื•ืคืื™ ื™ืœื“ื™ื, ื”ื™ืœื“ ืื•ื‘ื—ืŸ ืขื ADHD. ืžืื—ืจ ืฉื”ื™ืœื“ ืกื‘ืœ ืž-PKU, ื”ืจื•ืคื ื”ืžื˜ืคืœ ื”ื ื™ื— ื›ื™ ื™ื™ืชื›ืŸ ืฉื™ืฉ ืœื™ืœื“ ืžื—ืกื•ืจ ื‘-L-ื˜ื™ืจื•ื–ื™ืŸ, ื•ื”ื•ื ื ืชืŸ ืœื• ืืช ื—ื•ืžืฆืช ื”ืืžื™ื ื• ื”ื–ื• ื›ืชื•ืกืฃ ืชื–ื•ื ื”. ืœืคื™ ืขื•ืจื›ื™ ื”ืžื—ืงืจ, ืžืชืŸ ืชื•ืกืฃ L-ื˜ื™ืจื•ื–ื™ืŸ ื”ื‘ื™ื ืœืฉื™ืคื•ืจ ื“ืจืžื˜ื™ ื‘ืชืกืžื™ื ื™ ADHD ืืฆืœ ื”ื™ืœื“.

ืœืื•ืจ ื”ืขื“ื•ื™ื•ืช ื”ืงื™ื™ืžื•ืช, ืงืฉื” ืœื”ืกื™ืง ืžืกืงื ื•ืช ื—ื“-ืžืฉืžืขื™ื•ืช ืœื’ื‘ื™ L-ื˜ื™ืจื•ื–ื™ืŸ ื‘-ADHD. ื ื“ืจืฉื™ื ืžื—ืงืจื™ื ื’ื“ื•ืœื™ื ื•ืžืžื•ืฉื›ื™ื ื™ื•ืชืจ ื›ื“ื™ ืœื”ื’ื™ืข ืœืžืกืงื ื•ืช ืžื”ื™ืžื ื•ืช. ื›ืžื• ื›ืŸ, ื™ืฉ ืœื—ืงื•ืจ ืืช ื”ืกื•ื’ื™ื” ื”ืื ืงื™ื™ืžืช ืชืช-ืงื‘ื•ืฆื” ืฉืœ ืžื˜ื•ืคืœื™ื ืฉืขืฉื•ื™ื” ืœื”ื’ื™ื‘ ื‘ื’ืœืœ ื”ืฆื•ืจืš ื”ื‘ื™ื•ื›ื™ืžื™ ื”ื’ื“ื•ืœ ื™ื•ืชืจ ื‘ื—ื•ืžืฆืช ื”ืืžื™ื ื• ื”ื–ื• ืฉื›ื›ืœ ื”ื ืจืื” ืงื™ื™ื ื‘ืžืงืจื™ื ืฉืœ PKU. ืžื—ืงืจื™ื ืขืœ, ืื‘ืฅ,, ื‘ืจื–ืœ ื•ืืกื˜ืจื˜ื’ื™ื•ืช ืชื–ื•ื ืชื™ื•ืช ืฉื•ื ื•ืช ืžืฆื‘ื™ืขื™ื ืขืœ ื›ืš ืฉื›ื›ืœ ื”ื ืจืื” ืงื™ื™ืžื•ืช ืื•ืคืฆื™ื•ืช ืžื•ืขื™ืœื•ืช ื ื•ืกืคื•ืช ืขื‘ื•ืจ ADHD, ืืš ื”ืŸ ืžื—ื™ื™ื‘ื•ืช ื”ืฉื’ื—ื” ืฉืœ ื’ื•ืจื ืจืคื•ืื™ ืžื™ื•ืžืŸ.

ืชื•ืขืœืช ืœื‘ื™ืฆื•ืขื™ ื—ืฉื™ื‘ื” ื‘ืชื ืื™ ืกื˜ืจืก

ื ืจืื” ื›ื™ ื”ืขื“ื•ื™ื•ืช ื”ื˜ื•ื‘ื•ืช ื‘ื™ื•ืชืจ ืœืชื•ืขืœืช ืฉืœ L-ื˜ื™ืจื•ื–ื™ืŸ ื”ืŸ ืขื‘ื•ืจ ื”ืฉืคืขืชื• ืขืœ ืชืคืงื•ื“ ื”ืžื•ื— ืืฆืœ ืื ืฉื™ื ื”ื ืชื•ื ื™ื ื‘ืžืฆื‘ื™ื ืžืœื—ื™ืฆื™ื. ื™ื™ืชื›ืŸ ืฉื”ืฉืคืขืชื• ื“ื•ืžื” ืœื–ื• ืฉืœ ืื“ืคื˜ื•ื’ื ื™ื ืฆืžื—ื™ื™ื ืื—ืจื™ื, ื›ืžื• ื•ื™ืชื ื™ื” (ืืฉื•ื•ื’ื ื“ื”) ืื•ืจื•ื“ื™ื•ืœื”. ืจื‘ื™ื ืžื”ืžื—ืงืจื™ื ืขืœ L-ื˜ื™ืจื•ื–ื™ืŸ ื‘ื•ืฆืขื• ืขืœ-ื™ื“ื™ ื’ื•ืคื™ื ืฆื‘ืื™ื™ื ืฉื•ื ื™ื ืฉื”ืชืขื ื™ื™ื ื• ื‘ืชื•ืขืœืช ื”ืคื•ื˜ื ืฆื™ืืœื™ืช ืฉืœ ื—ื•ืžืฆืช ื”ืืžื™ื ื• ื”ื–ื•.

ืžื—ืงืจื™ื ื‘ื‘ืขืœื™ ื—ื™ื™ื ื”ืจืื• ื›ื™ ืžืฆื‘ื™ื ืžืœื—ื™ืฆื™ื ื™ื›ื•ืœื™ื ืœื’ืจื•ื ืœื™ืจื™ื“ื” ื‘ืจืžื•ืช ืฉืœ ื ื•ืจืืคื™ื ืคืจื™ืŸ ื•ื“ื•ืคืžื™ืŸ. ืžืชืŸ L-ื˜ื™ืจื•ื–ื™ืŸ ืœืื•ืชื ื‘ืขืœื™ ื”ื—ื™ื™ื ืžื•ื ืข ื™ืจื™ื“ื” ื‘ืจืžื•ืช ื”ืžื•ืœื™ื›ื™ื ื”ืขืฆื‘ื™ื™ื ื•ืžืฆืžืฆื ืฉื™ื ื•ื™ื™ ื”ืชื ื”ื’ื•ืช ื›ืชื•ืฆืื” ืžืกื˜ืจืก.

ืขืงืช ืงื•ืจ

ื ื™ืกื•ื™ ืจืืฉื•ื ื™ ื‘ื‘ื ื™ ืื“ื ื—ืฉืฃ ืื ืฉื™ ืฆื‘ื ืœื˜ืžืคืจื˜ื•ืจื•ืช ื ืžื•ื›ื•ืช ืขื ืจืžื•ืช ื—ืžืฆืŸ ื ืžื•ื›ื•ืช, ื›ืžื• ื‘ืกื‘ื™ื‘ื” ื”ืจืจื™ืช ื‘ื’ื•ื‘ื” ืจื‘. ื‘ืžื—ืงืจ ื”ื–ื” L-ื˜ื™ืจื•ื–ื™ืŸ, ื‘ื ื™ื’ื•ื“ ืœืคืœืฆื‘ื•, ื”ื‘ื™ื ืœื™ืจื™ื“ื” ืžืฉืžืขื•ืชื™ืช ื‘ื”ืฉืœื›ื•ืช ื”ืฉืœื™ืœื™ื•ืช. ืžืชืŸ ืชื•ืกืฃ ืฉืœ L-ื˜ื™ืจื•ื–ื™ืŸ ื”ื“ื’ื™ื ืชื•ืขืœืช ืขื‘ื•ืจ ืชืกืžื™ื ื™ื ืจื‘ื™ื, ื›ื•ืœืœ ื›ืื‘ื™ ืจืืฉ, ืชื—ื•ืฉืช ืงื•ืจ, ืชื—ื•ืฉืช ืžืฆื•ืงื”, ืขื™ื™ืคื•ืช, ืื™-ื ื•ื—ื•ืช ื‘ืฉืจื™ืจื™ื ื•ื™ืฉื ื•ื ื™ื•ืช. ื”ื ื‘ื“ืงื™ื ืฉืงื™ื‘ืœื• L-ื˜ื™ืจื•ื–ื™ืŸ ื’ื ื”ื“ื’ื™ืžื• ื‘ื™ืฆื•ืขื™ื ื˜ื•ื‘ื™ื ื™ื•ืชืจ ื‘ืžื˜ืœื•ืช ื”ืžื—ื™ื™ื‘ื•ืช ืžืืžืฅ ืžื ื˜ืœื™, ื›ื•ืœืœ ืชืจื’ื™ืœื™ ืžืชืžื˜ื™ืงื”, ืฉื™ืžื•ืฉ ื‘ืžืคื” ื•ื‘ืžืฆืคืŸ, ื–ื™ื”ื•ื™ ืชื‘ื ื™ื•ืช ื•ืžื“ื“ื™ื ื ื•ืกืคื™ื.

ื‘ืžื—ืงืจ ืื—ื“ ืฉืขืจืš ืฆื‘ื ืืจื”"ื‘ ื”ื ื‘ื“ืงื™ื ื ื—ืฉืคื• ืœืกื˜ืจืก ืขืœ-ื™ื“ื™ ื”ื•ืจื“ืช ื˜ืžืคืจื˜ื•ืจืช ื”ืœื™ื‘ื” ืฉืœ ื’ื•ืคื ื‘ืืžืฆืขื•ืช ืฉื”ื™ื™ื” ื‘ืžื™ื ืงืจื™ื. ื”ื ื”ื•ืขื‘ืจื• ืžื”ืžื™ื ื”ืงืจื™ื ืœื—ื“ืจ ืงืจ ื•ื”ืฉืœื™ืžื• ืžืกืคืจ ืžืฉื™ืžื•ืช ืœื”ืขืจื›ืช ื”ื‘ื™ืฆื•ืขื™ื ื”ื’ื•ืคื ื™ื™ื ื•ื”ืžื ื˜ืœื™ื™ื. ื”ืžืžืฆืื™ื ื”ื‘ื•ืœื˜ื™ื ื‘ื™ื•ืชืจ ื”ื™ื• ืฉื™ืคื•ืจื™ื ื‘ืงืœื™ืขื” ืœืžื˜ืจื” ื‘ืชื ืื™ ืขืงืช ืงื•ืจ ืœืื—ืจ ืžืชืŸ ืชื•ืกืฃ L-ื˜ื™ืจื•ื–ื™ืŸ. ืขื•ืจื›ื™ ื”ืžื—ืงืจ ืฆื™ื™ื ื• ื›ื™ ืงืœื™ืขื” ืœืžื˜ืจื” ื”ื™ื ืžืฉื™ืžื” ื”ืžื—ื™ื™ื‘ืช ื›ื™ืฉื•ืจื™ื ื’ื•ืคื ื™ื™ื ื•ื’ื ืžื ื˜ืœื™ื™ื.

ืขืงืช ืจืขืฉ

ืžื—ืงืจ ืื—ืจ ืฉื ืขืจืš ื‘ื”ื•ืœื ื“ ื—ืงืจ ืืช ื”ื”ืฉืคืขื•ืช ืฉืœ L-ื˜ื™ืจื•ื–ื™ืŸ ืขืœ ื”ืชืคืงื•ื“ ื”ืงื•ื’ื ื™ื˜ื™ื‘ื™ ืชื—ืช ืขืงืช ืจืขืฉ. ื”ื ื‘ื“ืงื™ื ื ื“ืจืฉื• ืœื‘ืฆืข ืžืกืคืจ ืžื˜ืœื•ืช ืžื ื˜ืœื™ื•ืช ืžืœื—ื™ืฆื•ืช ื‘ื–ืžืŸ ืฉื”ื ื”ืจื›ื™ื‘ื• ืื•ื–ื ื™ื•ืช ืฉื”ืฉืžื™ืขื• ืจืขืฉ ื”ืžื•ืจื›ื‘ ืžืฉื™ืœื•ื‘ ืฉืœ ืงื•ืœื•ืช ืžื‘ืจื™ื›ืช ืฉื—ื™ื™ื”, ืชื ื•ืขื” ืกื•ืื ืช, ืจืขืฉื™ ืจื›ื‘ืช ื•ืžืคืขืœ. ื”ื ื‘ื“ืงื™ื ืฉื™ืงื‘ืœื• L-ื˜ื™ืจื•ื–ื™ืŸ ื”ื“ื’ื™ืžื• ื‘ื™ืฆื•ืขื™ื ื˜ื•ื‘ื™ื ื™ื•ืชืจ ื‘ืžื‘ื—ื ื™ ื”ื—ืฉื™ื‘ื”. ื ื•ืกืฃ ืขืœ ื›ืš, L-ื˜ื™ืจื•ื–ื™ืŸ ื”ื‘ื™ื ื‘ื”ืชื—ืœื” ืœื™ืจื™ื“ื” ื‘ืœื—ืฅ ื”ื“ื, ื’ื ืื ื”ืฉื™ื ื•ื™ ื”ืชืื–ืŸ ื›ืขื‘ื•ืจ ืฉืขื”.

ืžื—ืกื•ืจ ื‘ืฉื™ื ื”

ื™ื“ื•ืข ืฉื’ื ืžื—ืกื•ืจ ื‘ืฉื™ื ื” ืคื•ื’ืข ื‘ื‘ื™ืฆื•ืขื™ื ื”ื’ื•ืคื ื™ื™ื ื•ื”ืžื ื˜ืœื™ื™ื. ืฆื™ ืืจืฆื•ืช ื”ื‘ืจื™ืช ื—ืงืจ ืืช ื”ืฉืคืขืช L-ื˜ื™ืจื•ื–ื™ืŸ ืขืœ ื ื‘ื“ืงื™ื ืฉืœื ื™ืฉื ื• ื‘ืžืฉืš 24 ืฉืขื•ืช. ืžืชืŸ ืชื•ืกืฃ L-ื˜ื™ืจื•ื–ื™ืŸ ื”ื‘ื™ื ืœืฉื™ืคื•ืจ ื’ื ื‘ื™ื›ื•ืœื•ืช ื”ืคืกื™ื›ื•ืžื•ื˜ื•ืจื™ื•ืช ื•ื’ื ื‘ืžื˜ืœื•ืช ื”ืžื—ื™ื™ื‘ื•ืช ืขืจื ื•ืช. ืžื—ืงืจ ืื—ืจ ื•ื“ื•ืžื” ื’ื ื—ืงืจ ืืช L-ื˜ื™ืจื•ื–ื™ืŸ ื‘ื”ืฉื•ื•ืื” ืœืงืคืื™ืŸ, ืืžืคื˜ืžื™ืŸ ื•ืชืจื•ืคื” ืื—ืจืช ืœืฉื™ืคื•ืจ ื”ื‘ื™ืฆื•ืขื™ื ื‘ืžืฆื‘ื™ื ืฉืœ ืžื—ืกื•ืจ ื‘ืฉื™ื ื”. ืืžื ื ืืžืคื˜ืžื™ืŸ ื”ื™ื” ื™ืขื™ืœ ื™ื•ืชืจ, ืื‘ืœ ื’ื L-ื˜ื™ืจื•ื–ื™ืŸ ื”ื‘ื™ื ืœืฉื™ืคื•ืจ ื‘ื–ื™ื›ืจื•ืŸ, ื‘ื™ื›ื•ืœืช ื”ื”ื™ืงืฉ ื”ืœื•ื’ื™ ื•ื‘ืžื˜ืœื•ืช ื—ื–ื•ืชื™ื•ืช ื”ืžื—ื™ื™ื‘ื•ืช ืขืจื ื•ืช.

ื‘ืงืจืช ื”ืคืจืขื•ืช

ืžื—ืงืจ ืงื˜ืŸ ืขืœ "ื‘ืงืจืช ื”ืคืจืขื•ืช" ื’ื ืžืฆื ืฉื™ืคื•ืจ ืžืกื•ื™ื ืœืื—ืจ ืžืชืŸ L-ื˜ื™ืจื•ื–ื™ืŸ. ื™ืฉ ืžืกืคืจ ืฉื™ื˜ื•ืช ืœืžื“ื™ื“ืช ื‘ืงืจืช ื”ืคืจืขื•ืช. ืฉื™ื˜ื” ืื—ืช ื”ื™ื ืœื”ืฆื™ื’ ืขืœ ืžืกืš ืžื—ืฉื‘ ืขื™ื’ื•ืœ ืื• ืžืจื•ื‘ืข, ื›ืืฉืจ ืขื‘ื•ืจ ื›ืœ ืฆื•ืจื” ืฆืจื™ืš ืœืœื—ื•ืฅ ืขืœ ื”ื›ืคืชื•ืจ ื”ืฉืžืืœื™ (ืขื‘ื•ืจ ื”ืขื™ื’ื•ืœ) ืื• ื”ื™ืžื ื™ (ืขื‘ื•ืจ ื”ืžืจื•ื‘ืข). ืขื ื–ืืช, ื›ืœ ืฆื•ืจื” ืžื•ืฆื’ืช ื‘ืฆื“ื• ื”ืฉืžืืœื™ ืื• ื”ื™ืžื ื™ ืฉืœ ื”ืžืกืš. ืžื™ืงื•ื ื”ืขืฆื ืœื ืงืฉื•ืจ ืœืชืฉื•ื‘ื” ื”ื ื›ื•ื ื”, ืืœื ืžืฉืžืฉ ื›ื”ืกื—ืช ืฉื ื•ืขื“ื” ืœื‘ืœื‘ืœ ืืช ื”ื ื‘ื“ืง. ื”ื•ื“ื’ื ื›ื™ L-ื˜ื™ืจื•ื–ื™ืŸ ืžืฉืคืจ ืืช ื”ื‘ื™ืฆื•ืขื™ื ื‘ืžื˜ืœื•ืช ื”ืžื—ื™ื™ื‘ื•ืช ื‘ืงืจืช ื”ืคืจืขื•ืช.

ืชื•ืขืœืช ืœื–ื™ื›ืจื•ืŸ ืชื—ืช ืกื˜ืจืก

ื ื™ืกื•ื™ ืงื˜ืŸ ื‘ื—ืŸ ืืช ื”ืชื•ืขืœืช ืฉืœ L-ื˜ื™ืจื•ื–ื™ืŸ ื‘ื‘ื™ืฆื•ืข ืžืฉื™ืžื•ืช ืคืฉื•ื˜ื•ืช ื•ื‘ืจื™ื‘ื•ื™ ืžืฉื™ืžื•ืช. ืžืชืŸ ืชื•ืกืฃ ื˜ื™ืจื•ื–ื™ืŸ ื”ื‘ื™ื ืœืฉื™ืคื•ืจ ื‘ื–ื™ื›ืจื•ืŸ ื‘ื‘ื™ืฆื•ืข ืžืฉื™ืžื•ืช ืžืจื•ื‘ื•ืช ืžืืชื’ืจื•ืช ื™ื•ืชืจ. ื‘ืžื—ืงืจ ืื—ืจ ืฉืขืจืš ืฆื‘ื ืืจืฆื•ืช ื”ื‘ืจื™ืช ื”ื•ืขืจื›ื• ื‘ื™ืฆื•ืขื™ ื”ื–ื™ื›ืจื•ืŸ ืฉืœ ื ื‘ื“ืงื™ื ืฉื ื—ืฉืคื• ืœืขืงืช ืงื•ืจ. ื”ื ื‘ื“ืงื™ื ื‘ืžื—ืงืจ ื–ื” ืฉื”ื• ื‘ืžื™ื ืงืจื™ื ื‘ื˜ืžืคืจื˜ื•ืจื” ืฉืœ ื›-10 ืžืขืœื•ืช ืฆืœื–ื™ื•ืก, ืžื” ืฉื”ื‘ื™ื ืœื™ืจื™ื“ื” ื‘ื˜ืžืคืจื˜ื•ืจืช ื”ืœื™ื‘ื” ืฉืœ ื”ื’ื•ืฃ, ื‘ืžืฉืš 90 ื“ืงื•ืช. ืื—ืจื™ ืขืงืช ื”ืงื•ืจ, ืžื‘ื—ื ื™ ื–ื™ื›ืจื•ืŸ ืงืฆืจ-ื˜ื•ื•ื— ื”ื“ื’ื™ืžื• ื‘ื™ืฆื•ืขื™ื ื˜ื•ื‘ื™ื ื™ื•ืชืจ ื‘ืงื‘ื•ืฆื” ืฉืงื™ื‘ืœื” L-ื˜ื™ืจื•ื–ื™ืŸ ืžืืฉืจ ื‘ืงื‘ื•ืฆื” ืฉืงื™ื‘ืœื” ืคืœืฆื‘ื•.

ืžื—ืงืจ ื“ื•ืžื” ืฉืขืจืš ืฆื™ ืืจืฆื•ืช ื”ื‘ืจื™ืช ื’ื ื”ื“ื’ื™ื ืชื•ืขืœืช ืขื‘ื•ืจ ืžื‘ื—ื ื™ ื–ื™ื›ืจื•ืŸ ืงืฆืจ-ื˜ื•ื•ื— ืœืื—ืจ ื—ืฉื™ืคื” ืœืงื•ืจ ื•ืžืชืŸ ืชื•ืกืฃ L-ื˜ื™ืจื•ื–ื™ืŸ. ืžืขื ื™ื™ืŸ ืฉื›ืืฉืจ ื”ื ื‘ื“ืงื™ื ืœื ื ื—ืฉืคื• ืœืงื•ืจ ืงื•ื“ื ืœื›ืŸ, ืœื ื”ื™ื™ืชื” ืœ-L-ื˜ื™ืจื•ื–ื™ืŸ ื›ืœ ื”ืฉืคืขื” ืขืœ ื”ื–ื™ื›ืจื•ืŸ. ื–ื” ืžืขื™ื“ ืขืœ ื›ืš ืฉื”ืชื•ืขืœืช ื›ื›ืœ ื”ื ืจืื” ืงื™ื™ืžืช ืจืง ื‘ืžืฆื‘ื™ ืœื—ืฅ.

ื“ื‘ืจื™ ืกื™ื›ื•ื

L-ื˜ื™ืจื•ื–ื™ืŸ ื”ื™ื ื—ื•ืžืฆืช ืืžื™ื ื• ืžืขื ื™ื™ื ืช. ื ืจืื” ืฉื”ื™ื ืขื•ื–ืจืช ืœืฉืคืจ ืืช ื”ืชืคืงื•ื“ ื”ืžื ื˜ืœื™ ื•ื”ื–ื™ื›ืจื•ืŸ ื‘ื‘ื™ืฆื•ืข ืคืขื™ืœื•ื™ื•ืช ืžืœื—ื™ืฆื•ืช ื•ื‘ืžืฆื‘ื™ ืœื—ืฅ. ืืžื ื ื”ืžื—ืงืจื™ื ืื™ื ื ืœื’ืžืจื™ ื‘ืจื•ืจื™ื, ืื‘ืœ ื™ื™ืชื›ืŸ ื›ื™ L-ื˜ื™ืจื•ื–ื™ืŸ ืขืฉื•ื™ื” ืœื”ื•ืขื™ืœ ื’ื ื‘ืžืงืจื™ื ืžืกื•ื™ืžื™ื ืฉืœ ื“ื™ื›ืื•ืŸ, ื‘ื”ื ืงื™ื™ื ืฆื•ืจืš ืžื˜ื‘ื•ืœื™ ื‘ืจืžื•ืช ื’ื‘ื•ื”ื•ืช ื™ื•ืชืจ ืฉืœ ื—ื•ืžืฆื•ืช ืืžื™ื ื•. ื‘ืืฉืจ ืœ-ADHD, ื”ืžื—ืงืจื™ื ืคื—ื•ืช ื—ื“-ืžืฉืžืขื™ื™ื.

ืœืžืจื‘ื” ื”ืžื–ืœ, ืœืคื™ ื”ืžื—ืงืจื™ื ืฉืคื•ืจืกืžื• ืื™ืŸ ืœ-L-ื˜ื™ืจื•ื–ื™ืŸ ื™ื•ืชืจ ืžื“ื™ ืชื•ืคืขื•ืช ืœื•ื•ืื™. ืชื•ืคืขื•ืช ื”ืœื•ื•ืื™ ื”ืฉื›ื™ื—ื•ืช ื‘ื™ื•ืชืจ ืฉื“ื•ื•ื—ื• ื”ืŸ ื›ืื‘ ืจืืฉ, ืขื™ื™ืคื•ืช, ืฆืจื‘ืช ื•ื‘ื—ื™ืœื”. ื‘ื“ืจืš ื›ืœืœ ืžื™ื ื•ื ื™ื ืกื‘ื™ืจื™ื ืฉืœ ื—ื•ืžืฆืช ื”ืืžื™ื ื• ื”ื–ื• ื ืกื‘ืœื™ื ื”ื™ื˜ื‘.

ื”ืคื ื™ื•ืช:

  1. Alabsi A, Khoudary AC, Abdelwahed W. The Antidepressant Effect of L-Tyrosine-Loaded Nanoparticles: Behavioral Aspects [published correction appears in Ann Neurosci. 2019 Jan;25(3):141-151]. Ann Neurosci. 2016;23(2):89-99. doi:10.1159/000443575
  2. Banderet LE, Lieberman HR. Treatment with tyrosine, a neurotransmitter precursor, reduces environmental stress in humans. Brain Res Bull. 1989;22(4):759-762. doi:10.1016/0361-9230(89)90096-8
  3. Deijen JB, Orlebeke JF. Effect of tyrosine on cognitive function and blood pressure under stress. Brain Res Bull. 1994;33(3):319-323. doi:10.1016/0361-9230(94)90200-3
  4. Gelenberg AJ, Wojcik JD, Growdon JH, Sved AF, Wurtman RJ. Tyrosine for the treatment of depression. Am J Psychiatry. 1980;137(5):622-623. doi:10.1176/ajp.137.5.622
  5. Goldberg IK. L-tyrosine in depression. Lancet. 1980;2(8190):364-365. doi:10.1016/s0140-6736(80)90356-6
  6. Magill RA, Waters WF, Bray GA, et al. Effects of tyrosine, phentermine, caffeine D-amphetamine, and placebo on cognitive and motor performance deficits during sleep deprivation. Nutr Neurosci. 2003;6(4):237-246. doi:10.1080/1028415031000120552
  7. Mahoney CR, Castellani J, Kramer FM, Young A, Lieberman HR. Tyrosine supplementation mitigates working memory decrements during cold exposure. Physiol Behav. 2007;92(4):575-582. doi:10.1016/j.physbeh.2007.05.003
  8. McLean A, Rubinsztein JS, Robbins TW, Sahakian BJ. The effects of tyrosine depletion in normal healthy volunteers: implications for unipolar depression. Psychopharmacology (Berl). 2004;171(3):286-297. doi:10.1007/s00213-003-1586-8
  9. Meyers S. Use of neurotransmitter precursors for treatment of depression. Altern Med Rev. 2000;5(1):64-71.
  10. Mouret J, Lemoine P, Minuit MP, Robelin N. La L-tyrosine guรฉrit, immรฉdiatement et ร  long terme, les dรฉpressions dopamino-dรฉpendantes (DDD). Etude clinique et polygraphique [L-tyrosine cures, immediate and long term, dopamine-dependent depressions. Clinical and polygraphic studies]. C R Acad Sci III. 1988;306(3):93-98.
  11. Nemzer ED, Arnold LE, Votolato NA, McConnell H. Amino acid supplementation as therapy for attention deficit disorder. J Am Acad Child Psychiatry. 1986;25(4):509-513. doi:10.1016/s0002-7138(10)60010-6
  12. Neri DF, Wiegmann D, Stanny RR, Shappell SA, McCardie A, McKay DL. The effects of tyrosine on cognitive performance during extended wakefulness. Aviat Space Environ Med. 1995;66(4):313-319.
  13. O'Brien C, Mahoney C, Tharion WJ, Sils IV, Castellani JW. Dietary tyrosine benefits cognitive and psychomotor performance during body cooling. Physiol Behav. 2007;90(2-3):301-307. doi:10.1016/j.physbeh.2006.09.027
  14. Posner J, Gorman D, Nagel BJ. Tyrosine supplements for ADHD symptoms with comorbid phenylketonuria. J Neuropsychiatry Clin Neurosci. 2009;21(2):228-230. doi:10.1176/jnp.2009.21.2.228
  15. Rauch TM, Lieberman HR. Tyrosine pretreatment reverses hypothermia-induced behavioral depression. Brain Res Bull. 1990;24(1):147-150. doi:10.1016/0361-9230(90)90299-f
  16. Reimherr FW, Wender PH, Wood DR, Ward M. An open trial of L-tyrosine in the treatment of attention deficit disorder, residual type. Am J Psychiatry. 1987;144(8):1071-1073. doi:10.1176/ajp.144.8.1071
  17. Shurtleff D, Thomas JR, Schrot J, Kowalski K, Harford R. Tyrosine reverses a cold-induced working memory deficit in humans. Pharmacol Biochem Behav. 1994;47(4):935-941. doi:10.1016/0091-3057(94)90299-2
  18. Thomas JR, Lockwood PA, Singh A, Deuster PA. Tyrosine improves working memory in a multitasking environment. Pharmacol Biochem Behav. 1999;64(3):495-500. doi:10.1016/s0091-3057(99)00094-5
  19. Wood DR, Reimherr FW, Wender PH. Amino acid precursors for the treatment of attention deficit disorder, residual type. Psychopharmacol Bull. 1985;21(1):146-149.
  20. Zhao X, Zhang H, Wu Y, Yu C. The efficacy and safety of St. John's wort extract in depression therapy compared to SSRIs in adults: A meta-analysis of randomized clinical trials. Adv Clin Exp Med. 2023;32(2):151-161. doi:10.17219/acem/152942

โ€‹ื›ืชื‘ ื•ื™ืชื•ืจ:โ€‹ ืžืจื›ื– ื”ื‘ืจื™ืื•ืช ื”ื–ื” ืœื ื ื•ืขื“ ืœืื‘ื—ืŸ,,, โ€‹ื”ืฆื’ ืขื•ื“